SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Network and Edge (NEX), Mobileye, Accelerated Computing Systems and Graphics (AXG), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The NEX segment offers computing system solutions from inflexible fixed-function hardware to general-purpose compute, acceleration, and networking devices running cloud native software on programmable hardware. The Mobileye segment develops driving assistance and self-driving solutions. The AXG segment provides products and technologies designed to help customers solve the toughest computational problems. Its products include CPUs for high-performance computing and GPUs targeted for a range of workloads and platforms, from gaming and content creation on client devices to delivering media and gaming in the cloud, and the most demanding high-performance computing and AI workloads on supercomputers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968 and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Intel is heavily trending after a disappointing forward outlook sparked a fierce debate among investors, with many anticipating further declines due to weak guidance. However, a significant portion of the community views the sharp pullback as an overreaction and a strategic buying opportunity, citing strong underlying demand and long-term potential in its foundry initiatives.

SPDR Gold Trust - SPDR Gold Shares

SPDR Gold Shares ETF

GLD is trending strongly as geopolitical and economic uncertainties drive a significant flight to safety into precious metals, with many in the community anticipating further record highs as fiat currency trust erodes. However, a vocal segment views the rapid ascent as an unsustainable "mania" and "bubble," expecting a sharp correction, especially with recent de-escalation reports fueling debate over gold's true underlying drivers.

Altimmune, Inc. is a clinical stage biopharmaceutical company, which focuses on the development of novel peptide-based therapeutics for the treatment of obesity and liver diseases. The company's lead product candidate, pemvidutide, is a GLP-1/glucagon dual receptor agonist that is being developed for the treatment of obesity and NASH. In addition, Altimmune is developing HepTcell, an immunotherapeutic designed to achieve a functional cure for chronic hepatitis B. The company was founded in 1997 and is headquartered in Gaithersburg, MD.

Altimmune Inc

Altimmune is seeing increased attention following the FDA's Breakthrough Therapy Designation for its lead asset, pemvidutide, for metabolic dysfunction-associated steatohepatitis. The community is buzzing with optimism about pemvidutide's best-in-class profile and eagerly awaiting potential strategic partnerships or an acquisition, which many believe the new CEO is poised to execute. This sentiment is amplified by notable price appreciation and trading volume, suggesting a market rerating in the active GLP-1 and MASH sector.

Sensei Biotherapeutics, Inc. is a clinical-stage biopharmaceutical company which focuses on the discovery, development, and delivery of next generation immunotherapies for the treatment of cancer and infectious diseases. The company was founded in 1999 and is headquartered in Rockville, MD.

Sensei Biotherapeutics Inc

Sensei Biotherapeutics (SNSE) is trending due to intense community speculation around a potential short squeeze, fueled by its extremely low float and historical volatility. While many bulls anticipate a significant breakout, a strong contingent of skeptics warns of a pump-and-dump, citing the company's ongoing strategic review for maximizing shareholder value, which includes exploring asset sales, mergers, or an orderly wind-down of operations.

Movano, Inc. is a health-focused technology company. The firm uses non-invasive technology to enable individuals and their healthcare partners to measure and manage their health conditions. It offers solutions through the app, the cloud, the wearable, and the sensor. The company was founded by Michael Aaron Leabman in January 2018 and is headquartered in Pleasanton, CA.

Movano Inc

Movano Inc. is experiencing intense trading activity as its merger partner, Corvex, announced a long-term NVIDIA H200 GPU deployment, driving significant speculative interest. Traders are sharply divided between those bullish on the low float and AI narrative, and those concerned about prior dilution history and the fundamental value of simply utilizing NVIDIA's hardware.

USA Rare Earth, Inc. is domestic supplier of rare earth magnets and heavy rare earth elements. It is developing a vertically integrated, domestic supply chain for rare earth element magnet production, with a facility in Stillwater, Oklahoma, and mining rights to the Round Top heavy rare earth and critical minerals deposit in West Texas. The company was founded in May 2019 and is headquartered in Stillwater, OK.

USA Rare Earth Inc. - Ordinary Shares - Class A

USA Rare Earth Inc

USA Rare Earth (USAR) is trending after announcing significant financial backing from the French government for a new rare earth metal and alloy production facility, aimed at bolstering integrated supply chains. This strategic development, coupled with partnerships advancing its US-based projects and the launch of a new leveraged ETF, is igniting community discussion about its potential for substantial growth amidst the intensifying global race for critical minerals.

First Majestic Silver Corp. engages in the production, development, exploration and acquisition of mineral properties. It owns and operates producing mines in México including the La Encantada Silver Mine, La Parrilla Silver Mine, San Martin Silver Mine, La Guitarra Silver Mine, Del Toro Silver Mine, Santa Elena Silver & Gold Mine, and San Dimas Silver & Gold Mine. The company was founded by Keith Neumeyer on September 26, 1979 and is headquartered in Vancouver, Canada.

First Majestic Silver Corporation

First Majestic Silver is a major talking point as silver prices surge towards uncharted territory, leading to widespread anticipation of a "parabolic" catch-up rally for undervalued miners like AG. The community is buzzing about strong production numbers, a recently doubled dividend, and the potential for massive profits, despite ongoing concerns about market manipulation. This enthusiasm reflects a broader belief that silver's true value is being realized amid high industrial demand and physical supply constraints.

Hycroft Mining Holding Corp. engages in the exploration, mining, and development of gold and silver properties. The company was founded on August 28, 2017 and is headquartered in Winnemucca, NV.

Hycroft Mining Holding Corporation - Ordinary Shares - Class A

Hycroft Mining Holding Corp

Hycroft Mining is trending due to exceptionally high-grade silver drill results from its Vortex system and a surging silver market, fueling speculation around its resource potential. The community is actively discussing the stock's significant short interest, anticipating a potential squeeze, and noting ongoing accumulation by prominent investors. This activity, combined with broader bullish sentiment in precious metals, positions the company for continued conversation and scrutiny as an updated resource report is awaited.

BlackRock Institutional Trust Company N.A. - iShares Silver Trust

iShares Silver Trust

iShares Silver Trust (SLV) is experiencing an intense rally, with community discussions buzzing about its spot price nearing the highly anticipated triple-digit level. This surge is reportedly fueled by increasing investor demand, particularly from India, alongside persistent concerns over physical supply shortages and ongoing currency debasement. Bears are actively being squeezed as many on the street anticipate further upward momentum driven by strong industrial demand from sectors like solar, EVs, and AI.

Redwire Corp. manufactures and supplies space equipment. It offers critical space solutions and reliability components for the next generation space economy with IP for solar power generation and in-space 3D printing and manufacturing. It assists its customers in solving challenges of future space missions. The company was founded in 2020 and is headquartered in Jacksonville, FL.

Redwire Corporation

Redwire Corp

Redwire is a top trending stock, driven by an unprecedented surge in trading volume and substantial institutional absorption of a major shareholder's sell-off, which the community sees as a strong vote of confidence. Investors are actively discussing the company's crucial role in the burgeoning space and defense sectors, pointing to its diversified contracts and innovative infrastructure as catalysts for significant future growth. This strong bullish sentiment persists despite ongoing conversations about potential share dilution.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Talphera (NASDAQ:TLPH) Stock Price Down 2.7% - Here's Why

Talphera (NASDAQ:TLPH) Stock Price Down 2.7% - Here's What Happened...

Talphera (NASDAQ:TLPH) Trading 3.2% Higher - Here's Why

Talphera (NASDAQ:TLPH) Shares Up 3.2% - Here's What Happened...

Talphera (NASDAQ:TLPH) Releases Earnings Results, Beats Estimates By $0.01 EPS

Talphera (NASDAQ:TLPH - Get Free Report) issued its earnings results on Wednesday. The company reported ($0.11) EPS for the quarter, topping analysts' consensus estimates of ($0.12) by $0.01...

Talphera Announces Third Quarter 2025 Financial Results and Provides Corporate Update

Talphera Announces Third Quarter 2025 Financial Results and Provides Corporate Update Talphera Announces Third Quarter 2025 Financial Results and Provides Corporate Update PR Newswire SAN MATEO...

Earnings Outlook For Talphera

Talphera Announces the Appointment of Joe Todisco to Board of Directors

Talphera Announces the Appointment of Joe Todisco to Board of Directors Talphera Announces the Appointment of Joe Todisco to Board of Directors PR Newswire SAN MATEO, Calif., Oct. 21, 2025 SAN MATEO...

Talphera, Inc. engages in the development and commercialization of therapies used in medically supervised settings. The firm's portfolio includes DSUVIA, DZUVEO, Zalviso, ARX-02 and ARX-03. The company was founded by Thomas A. Schreck and Pamela Pierce Palmer on July 13, 2005 and is headquartered in San Mateo, CA.

Talphera Inc.

Policy uncertainty from Trump

Earnings & guidance

Options / dealer positioning

Liquidity & algos

Markets are reacting to a mix of policy headlines, earnings, and positioning. We want to hear what you think is driving volatility the most right now.

TLPH
Acelrx Pharmaceuticals Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest TLPH News

TLPHAcelrx Pharmaceuticals Inc